vs
Side-by-side financial comparison of FLYEXCLUSIVE INC. (FLYX) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
FLYEXCLUSIVE INC. is the larger business by last-quarter revenue ($92.1M vs $57.3M, roughly 1.6× RHYTHM PHARMACEUTICALS, INC.). FLYEXCLUSIVE INC. runs the higher net margin — -4.6% vs -83.0%, a 78.3% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 19.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 21.9%).
FLYEXCLUSIVE INC. is a U.S.-headquartered private aviation services provider that offers private jet charter, aircraft management, maintenance repair, and fractional ownership programs. It primarily serves high-net-worth individuals, corporate clients, and government entities across North America, delivering personalized on-demand air travel solutions prioritizing safety and convenience.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
FLYX vs RYTM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $92.1M | $57.3M |
| Net Profit | $-4.3M | $-47.5M |
| Gross Margin | 13.7% | 91.6% |
| Operating Margin | -12.3% | -82.2% |
| Net Margin | -4.6% | -83.0% |
| Revenue YoY | 19.8% | 36.9% |
| Net Profit YoY | 32.0% | -9.6% |
| EPS (diluted) | $-0.25 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | $92.1M | $51.3M | ||
| Q2 25 | $91.3M | $48.5M | ||
| Q1 25 | $88.1M | $32.7M | ||
| Q4 24 | — | $41.8M | ||
| Q3 24 | $76.9M | $33.3M | ||
| Q2 24 | $79.0M | $29.1M | ||
| Q1 24 | $80.0M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | $-4.3M | $-52.9M | ||
| Q2 25 | $-4.8M | $-46.6M | ||
| Q1 25 | $-5.4M | $-49.5M | ||
| Q4 24 | — | $-43.3M | ||
| Q3 24 | $-6.3M | $-43.6M | ||
| Q2 24 | $-5.2M | $-32.3M | ||
| Q1 24 | $-5.8M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | 13.7% | 89.3% | ||
| Q2 25 | 15.0% | 88.6% | ||
| Q1 25 | 12.8% | 88.8% | ||
| Q4 24 | — | 90.9% | ||
| Q3 24 | 11.3% | 88.5% | ||
| Q2 24 | 7.9% | 89.9% | ||
| Q1 24 | 7.2% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | -12.3% | -102.6% | ||
| Q2 25 | -13.5% | -93.4% | ||
| Q1 25 | -16.7% | -143.7% | ||
| Q4 24 | — | -98.6% | ||
| Q3 24 | -27.2% | -132.0% | ||
| Q2 24 | -27.6% | -139.2% | ||
| Q1 24 | -34.3% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | -4.6% | -103.1% | ||
| Q2 25 | -5.2% | -96.1% | ||
| Q1 25 | -6.2% | -151.4% | ||
| Q4 24 | — | -103.6% | ||
| Q3 24 | -8.2% | -131.2% | ||
| Q2 24 | -6.5% | -110.9% | ||
| Q1 24 | -7.3% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | $-0.25 | $-0.82 | ||
| Q2 25 | $-0.26 | $-0.75 | ||
| Q1 25 | $-0.30 | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | $-0.32 | $-0.73 | ||
| Q2 24 | $-0.32 | $-0.55 | ||
| Q1 24 | $-0.35 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.7M | $388.9M |
| Total DebtLower is stronger | $123.9M | — |
| Stockholders' EquityBook value | $-434.2M | $139.1M |
| Total Assets | $448.1M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | $18.7M | $416.1M | ||
| Q2 25 | $15.8M | $291.0M | ||
| Q1 25 | $14.7M | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | $18.7M | $298.4M | ||
| Q2 24 | $9.3M | $319.1M | ||
| Q1 24 | $5.3M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | $123.9M | — | ||
| Q2 25 | $111.6M | — | ||
| Q1 25 | $121.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $197.9M | — | ||
| Q2 24 | $206.3M | — | ||
| Q1 24 | $209.4M | — |
| Q4 25 | — | $139.1M | ||
| Q3 25 | $-434.2M | $148.8M | ||
| Q2 25 | $-261.4M | $-11.9M | ||
| Q1 25 | $-281.5M | $18.9M | ||
| Q4 24 | — | $21.7M | ||
| Q3 24 | $-192.0M | $11.2M | ||
| Q2 24 | $-149.7M | $39.3M | ||
| Q1 24 | $-149.5M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | $448.1M | $506.9M | ||
| Q2 25 | $443.4M | $372.7M | ||
| Q1 25 | $466.8M | $386.7M | ||
| Q4 24 | — | $392.3M | ||
| Q3 24 | $487.1M | $363.6M | ||
| Q2 24 | $494.7M | $381.8M | ||
| Q1 24 | $524.1M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-209.0K | $-25.4M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -12.0% | — |
| Capex IntensityCapex / Revenue | 11.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-51.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | $-209.0K | $-26.6M | ||
| Q2 25 | $363.0K | $-23.3M | ||
| Q1 25 | $-10.5M | $-40.4M | ||
| Q4 24 | — | $-18.8M | ||
| Q3 24 | $-12.3M | $-25.2M | ||
| Q2 24 | $-16.2M | $-29.1M | ||
| Q1 24 | $-26.0M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-11.0M | — | ||
| Q2 25 | $353.0K | — | ||
| Q1 25 | $-14.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-25.7M | — | ||
| Q2 24 | $-26.6M | — | ||
| Q1 24 | $-64.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | -12.0% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | -16.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -33.5% | — | ||
| Q2 24 | -33.7% | — | ||
| Q1 24 | -80.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 11.7% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 17.5% | — | ||
| Q2 24 | 13.2% | — | ||
| Q1 24 | 48.2% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
